Substance / Medication

Etesevimab

Overview

Active Ingredient
etesevimab
RxNorm CUI
2477854

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
Bamlanivimab plus etesevimab treatment have a better outcome against COVID-19: A meta-analysis.
Xiang Huai-Rong, He Bei, Li Yun et al. · J Med Virol · 2022
PMID: 34936121Meta-Analysis
Monoclonal antibody infusion reaction with bamlanivimab and etesevimab in a 5-year-old male with coronavirus disease 2019: a case report.
Pillai Rajapillai L I, Dziel Caroline, Vogel Stephanie et al. · J Med Case Rep · 2023
PMID: 36823658Case ReportFull text (PMC)
Atrial fibrillation with aberrant ventricular conduction after receiving Bamlanivimab/Etesevimab: a case report.
Palazzo Anna Gloria, Zizza Antonella, Nuzzo Milva et al. · Curr Med Res Opin · 2022
PMID: 35608093Case Report
Safety of Intradialytic Bamlanivimab/Etesevimab Administration in Two COVID-19 Dialysis Outpatients.
Gasperoni Lorenzo, Abenavoli Chiara, Donati Gabriele et al. · Blood Purif · 2022
PMID: 35108709Case ReportFull text (PMC)
Lung Ultrasound Is Useful for Evaluating Lung Damage in COVID-19 Patients Treated with Bamlanivimab and Etesevimab: A Single-Center Pilot Study.
Cicco Sebastiano, Marozzi Marialuisa Sveva, Palumbo Carmen Alessandra et al. · Medicina (Kaunas) · 2023
PMID: 36837405OtherFull text (PMC)

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Etesevimab (substance)
SNOMED CT
127351000202102
UMLS CUI
C5421804
RxNorm CUI
2477854

Clinical Data

This intervention maps to 1 entities in the Ltrl knowledge graph.

1
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.